Stay informed with the latest litigation news. Explore now
Direct Compression Formulation And Process - EP3366283B1
EP3366283
- Application Number
- EP18165545A
- Filing Date
- Jan 17, 2005
- Status
- Granted And Under Opposition
- Jul 30, 2021
- Grant Date
- Sep 1, 2021
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3366283B1 was granted to Novartis on Sep 1, 2021 following the initial filing on Jan 17, 2005 under the application number EP18165545A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary
Patent Family New
Patent Oppositions (6)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents